These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 22672376)

  • 1. Commentary on Elkashef et al. (2012): just enough efficacy for a second look.
    Vocci F
    Addiction; 2012 Jul; 107(7):1307-8. PubMed ID: 22672376
    [No Abstract]   [Full Text] [Related]  

  • 2. Topiramate for the treatment of methamphetamine addiction: a multi-center placebo-controlled trial.
    Elkashef A; Kahn R; Yu E; Iturriaga E; Li SH; Anderson A; Chiang N; Ait-Daoud N; Weiss D; McSherry F; Serpi T; Rawson R; Hrymoc M; Weis D; McCann M; Pham T; Stock C; Dickinson R; Campbell J; Gorodetzky C; Haning W; Carlton B; Mawhinney J; Li MD; Johnson BA
    Addiction; 2012 Jul; 107(7):1297-306. PubMed ID: 22221594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topiramate as treatment for alcohol dependence.
    Ameisen O
    JAMA; 2008 Jan; 299(4):405; author reply 406-7. PubMed ID: 18230774
    [No Abstract]   [Full Text] [Related]  

  • 4. Commentary on Ling et al. (2012): The PROMETA™ treatment does not reduce methamphetamine use.
    Sofuoglu M
    Addiction; 2012 Feb; 107(2):370-1. PubMed ID: 22248141
    [No Abstract]   [Full Text] [Related]  

  • 5. Topiramate as treatment for alcohol dependence.
    Stringer S; Rueve M; Mossman D
    JAMA; 2008 Jan; 299(4):405-6; author reply 406-7. PubMed ID: 18230773
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of alcohol-use disorders.
    Caputo F; Bernardi M; Zoli G
    Lancet; 2009 May; 373(9674):1519; author reply 1519-20. PubMed ID: 19410705
    [No Abstract]   [Full Text] [Related]  

  • 7. Medications to treat alcohol dependence: adding to the continuum of care.
    Willenbring ML
    JAMA; 2007 Oct; 298(14):1691-2. PubMed ID: 17925523
    [No Abstract]   [Full Text] [Related]  

  • 8. Topiramate as treatment for alcohol dependence.
    Spaeth GL; Mantravadi AV
    JAMA; 2008 Jan; 299(4):405; author reply 406-7. PubMed ID: 18230775
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of riluzole augmentation in a patient with treatment-resistant obsessive-compulsive disorder, taking two other glutaminergic agents.
    Mahgoub N; Asemota B; Alexopoulos GS
    J Neuropsychiatry Clin Neurosci; 2011; 23(2):E24-5. PubMed ID: 21677213
    [No Abstract]   [Full Text] [Related]  

  • 10. Also Topiramate might have some benefit in psychopharmacological treatment of autism.
    Niederhofer H
    Med Hypotheses; 2008; 70(2):455. PubMed ID: 17656029
    [No Abstract]   [Full Text] [Related]  

  • 11. Neurostabilizers for migraine prevention. From dosage administration to patient expectations.
    Wright W
    Adv Nurse Pract; 2007 Feb; 15(2):52-4, 56-8, 85. PubMed ID: 19998927
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of acute topiramate dosing on methamphetamine-induced subjective mood.
    Johnson BA; Roache JD; Ait-Daoud N; Wells LT; Wallace CL; Dawes MA; Liu L; Wang XQ
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):85-98. PubMed ID: 16448579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptome profiling and pathway analysis of genes expressed differentially in participants with or without a positive response to topiramate treatment for methamphetamine addiction.
    Li MD; Wang J; Niu T; Ma JZ; Seneviratne C; Ait-Daoud N; Saadvandi J; Morris R; Weiss D; Campbell J; Haning W; Mawhinney DJ; Weis D; McCann M; Stock C; Kahn R; Iturriaga E; Yu E; Elkashef A; Johnson BA
    BMC Med Genomics; 2014 Dec; 7():65. PubMed ID: 25495887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What can we learn from the failure of yet another 'miracle cure' for addiction?
    Humphreys K
    Addiction; 2012 Feb; 107(2):237-9. PubMed ID: 22248129
    [No Abstract]   [Full Text] [Related]  

  • 15. mGluR5 antagonism attenuates methamphetamine reinforcement and prevents reinstatement of methamphetamine-seeking behavior in rats.
    Gass JT; Osborne MP; Watson NL; Brown JL; Olive MF
    Neuropsychopharmacology; 2009 Mar; 34(4):820-33. PubMed ID: 18800068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term treatment of cocaine and/or methamphetamine abuse with vigabatrin: ocular safety pilot results.
    Fechtner RD; Khouri AS; Figueroa E; Ramirez M; Federico M; Dewey SL; Brodie JD
    Arch Ophthalmol; 2006 Sep; 124(9):1257-62. PubMed ID: 16966620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Topiramate augmentation in treatment-resistant obsessive-compulsive disorder].
    Vinkers DJ; van der Wee NJ
    Tijdschr Psychiatr; 2008; 50(11):747-50. PubMed ID: 18991236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine-grain analysis of the treatment effect of topiramate on methamphetamine addiction with latent variable analysis.
    Ma JZ; Johnson BA; Yu E; Weiss D; McSherry F; Saadvandi J; Iturriaga E; Ait-Daoud N; Rawson RA; Hrymoc M; Campbell J; Gorodetzky C; Haning W; Carlton B; Mawhinney J; Weis D; McCann M; Pham T; Stock C; Dickinson R; Elkashef A; Li MD
    Drug Alcohol Depend; 2013 Jun; 130(1-3):45-51. PubMed ID: 23142494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of cognitive performance by topiramate: Blockage of automatic processes may be the underlying mechanism.
    Zullino DF; Benguettat D; Khazaal Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):787. PubMed ID: 17291662
    [No Abstract]   [Full Text] [Related]  

  • 20. Topiramate for the management of methamphetamine dependence: a pilot randomized, double-blind, placebo-controlled trial.
    Rezaei F; Ghaderi E; Mardani R; Hamidi S; Hassanzadeh K
    Fundam Clin Pharmacol; 2016 Jun; 30(3):282-9. PubMed ID: 26751259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.